NDC Package 72000-120-06 Xenleta

Lefamulin Acetate Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
Package Description:
6 VIAL, SINGLE-USE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-USE (72000-120-01)
Product Code:
Proprietary Name:
Non-Proprietary Name:
Lefamulin Acetate
Substance Name:
Lefamulin Acetate
Usage Information:
XENLETA is indicated for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
11-Digit NDC Billing Format:
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2198948 - lefamulin 150 MG in 15 ML Injection
  • RxCUI: 2198948 - 15 ML lefamulin 10 MG/ML Injection
  • RxCUI: 2198948 - lefamulin 150 MG per 15 ML Injection
  • RxCUI: 2198953 - Xenleta 150 MG in 15 ML Injection
  • RxCUI: 2198953 - 15 ML lefamulin 10 MG/ML Injection [Xenleta]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Nabriva Therapeutics Us, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    FDA Application Number:
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    Listing Expiration Date:
    Exclude Flag:
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72000-120-06?

    The NDC Packaged Code 72000-120-06 is assigned to a package of 6 vial, single-use in 1 carton / 15 ml in 1 vial, single-use (72000-120-01) of Xenleta, a human prescription drug labeled by Nabriva Therapeutics Us, Inc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 72000-120 included in the NDC Directory?

    Yes, Xenleta with product code 72000-120 is active and included in the NDC Directory. The product was first marketed by Nabriva Therapeutics Us, Inc. on September 09, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 72000-120-06?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 72000-120-06?

    The 11-digit format is 72000012006. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code